Connecticut Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,013
| Closed | -$261K | – | 339 |
|
2024
Q1 | $261K | Buy |
+2,013
| New | +$261K | 0.01% | 279 |
|
2023
Q4 | – | Sell |
-3,567
| Closed | -$432K | – | 328 |
|
2023
Q3 | $432K | Hold |
3,567
| – | – | 0.03% | 187 |
|
2023
Q2 | $408K | Hold |
3,567
| – | – | 0.03% | 167 |
|
2023
Q1 | $492K | Sell |
3,567
-5
| -0.1% | -$689 | 0.04% | 139 |
|
2022
Q4 | $463K | Buy |
3,572
+1,559
| +77% | +$202K | 0.04% | 119 |
|
2022
Q3 | $223K | Buy |
+2,013
| New | +$223K | 0.02% | 179 |
|
2021
Q1 | – | Sell |
-2,000
| Closed | -$341K | – | 207 |
|
2020
Q4 | $341K | Hold |
2,000
| – | – | 0.04% | 141 |
|
2020
Q3 | $281K | Hold |
2,000
| – | – | 0.03% | 164 |
|
2020
Q2 | $321K | Buy |
+2,000
| New | +$321K | 0.04% | 110 |
|
2020
Q1 | – | Sell |
-2,000
| Closed | -$258K | – | 156 |
|
2019
Q4 | $258K | Buy |
+2,000
| New | +$258K | 0.03% | 143 |
|